Jin, X., Sun, R., Li, Z., Wang, X., Xiong, X., Lu, W., Lyu, H., Xiao, X., Tian, Y., Zhang, H., Fang, Z., Wang, L. and Zhao, M. (2020) “CD22-targeted glyco-engineered natural killer cells offer a further treatment option for B-cell acute lymphoblastic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.284241.